Facebook Linkedin RSS Twitter Youtube
Home 2024

Ophthalmic diseases

Asimov and RevOpsis Therapeutics Ink Licensing Deal for Multispecific-Expressing Cell Line
Bioprocessing

Asimov and RevOpsis Therapeutics Ink Licensing Deal for Multispecific-Expressing Cell Line

Wet AMD Treatments Could Work Better If Both VEGF and ANGPTL4 Are Targeted
Drug Discovery

Wet AMD Treatments Could Work Better If Both VEGF and ANGPTL4 Are Targeted

Glaucoma Drug Could Counteract Tau Protein Buildup in Neurodegenerative Diseases
News

Glaucoma Drug Could Counteract Tau Protein Buildup in Neurodegenerative Diseases

Hubble Therapeutics Taps Andelyn to Manufacture Clinical Grade AAV for Eye Disorder Gene Therapy
Bioprocessing

Hubble Therapeutics Taps Andelyn to Manufacture Clinical Grade AAV for Eye Disorder Gene Therapy

Human Stem Cells Repair Retinas in Monkey Models of Macular Holes
News

Human Stem Cells Repair Retinas in Monkey Models of Macular Holes

To Reverse Aging’s Clock, Adjust the Cell’s Machinery
Insights

To Reverse Aging’s Clock, Adjust the Cell’s Machinery

Positive Phase II Bolsters Aura Bioscience’s Confidence in VDC-based Therapy for Ocular Melanomas
Cancer

Positive Phase II Bolsters Aura Bioscience’s Confidence in VDC-based Therapy for Ocular Melanomas

Cell/Tissue Manufacturing Platform from Cellino Attracts $25M in Funding from ARPA-H
Bioprocessing

Cell/Tissue Manufacturing Platform from Cellino Attracts $25M in Funding from ARPA-H

AAV Gene Therapy for LCA1 Improves Vision Dramatically
Drug Discovery

AAV Gene Therapy for LCA1 Improves Vision Dramatically

StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data
Drug Discovery

StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data

123...44Page 1 of 44
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.